TP53 and breast carcinoma: Cell death induction and cell growth inhibition were noticed at higher doses, including more than 10 μM of berberine treatment in breast cancer cells, due to the p53 upregulation under the nucleolar stress response caused by a noteworthy accumulation of berberine in the nucleoli [187].